Platelet-activating factor (PAF) is a potent mediator of inflammatory injury in renal diseases. PAF is degraded to inactive products by PAF acetylhydrolase. Recently, a point mutation (G to T transversion) of the PAF acetylhydrolase gene was observed at position 994, and this mutation was found to contribute to the variability in plasma PAF levels, with undetectable plasma PAF acetylhydrolase activity occurring in homozygous patients (TT genotype) and reduced levels of activity in heterozygous patients (GT genotype). Therefore, we investigated the effect of the PAF acetylhydrolase gene mutation on the pathogenesis and progression of immunoglobulin A (IgA) nephropathy. Genomic DNA was obtained from 89 children with IgA nephropathy and 100 controls. We identified the PAF acetylhydrolase gene mutation (G994T) by polymerase chain reaction. There was no significant difference in genotypic frequency between patients and controls. However, urinary protein excretion at the time of biopsy was significantly greater in patients with the GT/TT genotypes than in those with the GG genotype. The percentage of glomeruli with mesangial cell proliferation was significantly greater in patients with the GT/TT genotypes than in those with the GG genotype. These results indicate the PAF acetylhydrolase gene mutation may influence the degree of proteinuria and the extent of mesangial proliferation in the early stage of childhood IgA nephropathy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0272-6386(99)70357-4 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Sleeve gastrectomy improves HDL function examined by Apo-A1 and atherogenic indices in non-diabetic obese patients.
Cir Cir
January 2025
Department of General Surgery, Antalya Training and Research Hospital, Antalya, Turkey.
Objective: Dysregulation of lipid metabolism can be one of the pathophysiological mechanisms linking high-density lipoprotein cholesterol (HDL-C) dysfunction to obesity. The aim of the study is to show possible changes in lipid metabolism with atherogenic indices in obese patients after sleeve gastrectomy (SG) surgery.
Method: Thirty patients who had SG surgery for obesity were included in the prospective study.
Oxidative stress indexes as biomarkers of the severity in COVID-19 patients.
Int J Med Sci
December 2024
Department of Laboratory Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
: SARS-CoV-2 causes a global pandemic, with severe and critically ill COVID-19 patients often experiencing poor prognoses. Severe infection with SARS-CoV-2 is associated with oxidative stress (OS) and inflammation. Detecting markers of macromolecular damage caused by OS may provide valuable insights into disease progression.
View Article and Find Full Text PDFAssociation of Lipoprotein-Associated Phospholipase A2 and Lipoprotein(a) With the Risk of Recurrence Stroke in Patients With Acute Ischemic Stroke.
J Clin Lab Anal
December 2024
Department of Neurology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Article Synopsis
- The study explores the prognostic significance of lipoprotein-associated phospholipase A2 (Lp-PLA2) and lipoprotein(a) (Lp(a)) in predicting long-term stroke recurrence in patients with acute ischemic stroke (AIS).
- A total of 580 AIS patients were monitored over two years, with results showing that 17.41% experienced stroke recurrence, highlighting key risk factors such as age, diabetes, and levels of Lp-PLA2 and Lp(a).
- The results suggest that using both Lp-PLA2 and Lp(a) together offers a more effective and cost-efficient method for assessing stroke recurrence risk than looking at these factors individually.
Lipoprotein-associated phospholipase A2 and its possible association with COPD development: a case-control study.
BMC Pulm Med
November 2024
Health Management Center, The First Affiliated Hospital (Southwest Hospital) of Army Medical University, No.30, Gaotanyan street, Shapingba District, Chongqing, 400038, China.
Background: The association of lipoprotein-associated phospholipase A2 (Lp-PLA2) with various cardiovascular events has been well-established. However, the exploration of its potential involvement in Chronic obstructive pulmonary disease (COPD) is currently limited. Therefore, our study aims to examine the relationship between Lp-PLA2 and pulmonary conditions, including emphysema, obstructive ventilatory dysfunction as well as small airway dysfunction, to provide further evidence of a possible association with COPD development.
View Article and Find Full Text PDFHigh expression of PLA2G2A in fibroblasts plays a crucial role in the early progression of carotid atherosclerosis.
J Transl Med
October 2024
The Clinical Systems Biology Laboratories of the First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe Road, Zhengzhou, 450052, Henan, China.
Article Synopsis
- In mouse models, knocking out the PLA2G2A gene reduces atherosclerotic plaque volume, but clinical trials with the sPLA2 inhibitor Varespladib haven’t effectively lowered cardiovascular risk, highlighting the need for further research on PLA2G2A's mechanisms.
- Using single-cell transcriptome data from carotid plaques with patient info, researchers found that PLA2G2A is mainly expressed in vascular fibroblasts and interacts significantly with macrophages, especially in early plaque stages related to inflammation.
- The study concludes that PLA2G2A promotes early plaque progression by activating macrophage-related pathways and suggests its serum levels could be valuable for diagnosing mild carotid artery stenosis.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!